IMMUNOGLOBULIN G4 (227-PROLINE), ANTI-(HUMAN LEPTIN RECEPTOR) (HUMAN MONOCLONAL REGN4461 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN4461 .KAPPA.-CHAIN, DIMER
Generalized Lipodystrophy (GLD)
monoclonal_antibodyDormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Generalized Lipodystrophy (GLD) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Mibavademab Regeneron Pharmaceuticals | Phase 3 | NR |
Same molecule, other indications
IMMUNOGLOBULIN G4 (227-PROLINE), ANTI-(HUMAN LEPTIN RECEPTOR) (HUMAN MONOCLONAL REGN4461 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN4461 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →